DE PERI, Luca Mario
 Distribuzione geografica
Continente #
NA - Nord America 2.826
AS - Asia 1.304
EU - Europa 1.022
SA - Sud America 269
AF - Africa 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.455
Nazione #
US - Stati Uniti d'America 2.796
CN - Cina 511
SG - Singapore 396
UA - Ucraina 289
BR - Brasile 235
HK - Hong Kong 168
DE - Germania 166
IT - Italia 138
GB - Regno Unito 112
FI - Finlandia 77
RU - Federazione Russa 61
VN - Vietnam 59
TR - Turchia 58
IN - India 54
IE - Irlanda 52
FR - Francia 35
PL - Polonia 24
CA - Canada 20
AR - Argentina 16
BE - Belgio 15
CZ - Repubblica Ceca 14
BD - Bangladesh 12
NL - Olanda 9
SE - Svezia 9
ID - Indonesia 7
ZA - Sudafrica 6
AU - Australia 5
IQ - Iraq 5
MA - Marocco 5
MX - Messico 5
CO - Colombia 4
ET - Etiopia 4
IL - Israele 4
IR - Iran 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
ES - Italia 3
EU - Europa 3
JP - Giappone 3
KE - Kenya 3
LT - Lituania 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
EG - Egitto 2
JO - Giordania 2
LV - Lettonia 2
NP - Nepal 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 5.455
Città #
Fairfield 352
Woodbridge 335
Jacksonville 216
Singapore 210
Houston 206
Ashburn 195
Hong Kong 165
Ann Arbor 154
Seattle 139
Cambridge 134
Wilmington 131
Beijing 112
Chandler 111
Princeton 98
Nanjing 92
New York 75
The Dalles 62
Dublin 52
Lancaster 52
Brescia 46
Istanbul 44
Los Angeles 34
Helsinki 32
Munich 32
Moscow 28
Dearborn 24
Warsaw 24
Changsha 23
Milan 23
Des Moines 22
Buffalo 21
Dallas 20
Nanchang 20
Tianjin 19
Shanghai 18
Shenyang 18
Hebei 17
São Paulo 17
Ho Chi Minh City 16
San Francisco 16
Brussels 15
Jinan 15
Hanoi 14
London 14
Redondo Beach 14
Chicago 11
Kunming 11
Zhengzhou 11
Jiaxing 10
Norwalk 10
San Diego 10
Turku 10
Brno 9
Guangzhou 9
Hangzhou 9
Frankfurt am Main 8
Ningbo 8
Boardman 7
Augusta 6
Fortaleza 6
Kocaeli 6
Montreal 6
Porto Alegre 6
Rio de Janeiro 6
San Mateo 6
Toronto 6
Belo Horizonte 5
Brooklyn 5
Denver 5
Nuremberg 5
Olomouc 5
Orange 5
Redwood City 5
Santa Clara 5
Amsterdam 4
Ankara 4
Brasília 4
Campinas 4
Contagem 4
Delhi 4
Dong Ket 4
Phoenix 4
Rome 4
Salt Lake City 4
Stockholm 4
Washington 4
Aracaju 3
Ardabil 3
Atlanta 3
Can Tho 3
Castel Goffredo 3
Chennai 3
Curitiba 3
Dhaka 3
Giarre 3
Gravataí 3
Jakarta 3
Kilburn 3
Lanzhou 3
Lappeenranta 3
Totale 3.778
Nome #
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 230
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 225
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 177
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 173
Cognitive remediation in schizophrenia. 164
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 151
Factors Associated With Brain Heterogeneity in Schizophrenia 151
Cognitive remediation in schizophrenia: a controlled study 145
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 144
Cognitive remediation in the early course of schizophrenia: a critical review. 142
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 134
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 131
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 131
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 128
Uso della PET e della SPECT in psichiatria 128
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 125
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. 122
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 122
A meta-analysis of quantitative magnetic resonance imaging study in first-episode schizophrenia. 120
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 119
Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials 118
Interventi non farmacologici nelle fasi precoci della schizofrenia: focus sul rimedio cognitivo. Non-pharmacological interventions in early schizophrenia: focus on cognitive remediation 116
Brain morphology in sib-pairs discordant for schizophrenia: preliminary results from a MRI quantitative study. 109
Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials. 108
Variation in brain structure volumes in schizophrenia: A commentary 108
New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process? 107
Late-onset schizophrenia: epidemiology, clinical profile, prognosis, and treatment considerations 102
Schizophrenia 102
Cognitive rehabilitation of patients with schizophrenia. 99
Brain morphological abnormalities at the onset of schizophrenia and other psychotics disorders: a review of the evidence 97
Farmacoterapia dell'aggressività 96
Neuropsichological performance and brain morphology in sib-pairs discordant for schizophrenia 96
Brain imaging in first episode schizophrenia. 94
Meta-analysis of magnetic resonance imaging studies in first episode bipolar disorder 92
Subjective cognitive imparments in schizophrenia patients: clinical and neuropsychological correlates. 91
Disturbo borderline di personalità: effetti di genere. 84
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting 81
Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder 78
Symptomatic remission in deficit and non deficit schizophrenia: data from a multicentric prospettive 5-year follow-up study. 77
Subjective experience of cognitive deficits in schizophrenic patients treated with antypsychotics: clinical, neuropsychological and treatment correlates. 76
Subjective experience of schizophrenic patients treated with antipsychotics: clinical and pharmacological correlates 74
L'importanza della prevenzione delle ricadute nel trattamento a lungo termine della schizofrenia : efficacia dei farmaci antipsicotici. 71
Longitudinal stability and long term outcome of schizophrenia deficit and nondeficit subtype. 69
Remissione sintomatologica nella schizofrenia deficitaria e non deficitaria: dati di uno studio multicentrico prospettico di follow-up a 5 anni. 69
Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia 68
Editorial: Trajectories of Brain Abnormalities in Early Schizophrenia 68
Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed 56
Commentary on: it might be a wonderful opportunity when patients with a psychotic disorder use cannabis 52
Are Schizophrenic disorders with or without early cannabis use neurobiologically distinct disease entities? A meta-analysis of magnetic resonance imaging studies 51
Editorial: Unveiling the neurobiological underpinnings of cognitive dysfunction in patients with schizophrenia 36
Totale 5.507
Categoria #
all - tutte 26.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 77 20 74 82 65 93 30
2021/2022361 18 78 1 13 4 14 26 28 14 38 27 100
2022/2023351 58 4 1 28 35 96 0 28 51 6 16 28
2023/2024351 26 16 20 17 9 79 8 18 86 1 10 61
2024/2025784 15 6 1 95 79 81 67 10 83 65 162 120
2025/2026912 177 237 125 188 159 26 0 0 0 0 0 0
Totale 5.507